Notification Process for Drug Shortages Explained in Draft Guidance

The FDA has issued a draft guidance on how and when applicants and manufacturers should provide information on interruptions or discontinuations of drugs, biological products and active pharmaceutical ingredients to help the agency prevent or mitigate shortages.
Source: Drug Industry Daily